Published in West J Med on April 01, 1974
Soluble antigens of mycelia and spherules in the in vitro detection of immunity to Coccidioides immitis. Infect Immun (1974) 1.11
Cell-mediated immunity and its role in resistance to infection. West J Med (1977) 0.85
Transfer of cellular hypersensitivity in chronic mucocutaneous candidiasis monitored in vivo and in vitro. Cell Immunol (1970) 1.64
The use of amphotericin B in the treatment of coccidioidal disease. Am J Med (1959) 1.52
Chronic mucocutaneous moniliasis with impaired delayed hypersensitivity. Clin Exp Immunol (1970) 1.45
A therapeutic dilemma. The treatment of disseminated coccidioidomycosis with amphotericin B. Ann Intern Med (1962) 1.25
An evaluation of transfer factor as immunotherapy for patients with lepromatous leprosy. N Engl J Med (1972) 1.20
An improved in vitro assay for lymphotoxin. Cell Immunol (1972) 1.14
Coccidioidal meningitis. A diagnostic challenge. Am J Med (1970) 1.11
Transfer factor deficiency response--a mechanism of anergy in Boeck's sarcoid. Trans Assoc Am Physicians (1968) 1.10
Chromatography of the human tuberculin delayed-type hypersensitivity transfer factor. J Allergy (1963) 0.96
Transfer factor therapy in a patient with progressive primary tuberculosis. Ann Intern Med (1973) 0.94
Early recognition and therapy of disseminated coccidioidomycosis. Am J Med (1961) 0.92
Coccidioidomycosis: a report of 300 new cases. GP (1969) 0.81
Laboratory evaluation of a rapid, automatic susceptibility testing system: report of a collaborative study. Antimicrob Agents Chemother (1975) 17.12
An improved single-disk method for testing the antibiotic susceptibility of rapidly-growing pathogens. Am J Clin Pathol (1970) 8.90
Quality control limits for ampicillin, carbenicillin, mezlocillin, and piperacillin disk diffusion susceptibility tests: a collaborative study. J Clin Microbiol (1981) 8.49
Molecular cloning and expression of a receptor for human tumor necrosis factor. Cell (1990) 5.73
Lymphocyte in vitro cytotoxicity: mechanisms of immune and non-immune small lymphocyte mediated target L cell destruction. J Immunol (1968) 4.66
A rapid (4--6-hour) urine-culture system for direct identification and direct antimicrobial susceptibility testing. Am J Clin Pathol (1979) 2.51
Lymphocyte cytotoxicity in vitro: activation and release of a cytotoxic factor. Nature (1968) 2.24
Kinetics and mechanisms of recombinant human interleukin 1 and tumor necrosis factor-alpha-induced changes in circulating numbers of neutrophils and lymphocytes. J Immunol (1987) 2.08
Meningitis due to Haemophilus influenzae type b resistant to ampicillin and chloramphenicol. J Pediatr (1980) 1.96
Lymphocyte in vitro cytotoxicity: characterization of human lymphotoxin. Proc Natl Acad Sci U S A (1968) 1.95
Lymphocyte in vitro cytotoxicity: specific release of lymphotoxin-like materials from tuberculin-sensitive lymphoid cells. Nature (1969) 1.94
Antimicrobial resistance in long-term-care facilities. Infect Control Hosp Epidemiol (1996) 1.90
Chromatographic alterations in transfer RNA's accompanying speciation, differentiation and tumor formation. J Mol Biol (1968) 1.88
Efficient, inefficient, and abortive infection of different mammalian cells by small RNA viruses. Virology (1967) 1.88
Importance of sulfadiazine resistance in meningococcal disease in civilians. N Engl J Med (1965) 1.80
Homograft target cells: contact destruction in vitro by immune macrophages. Science (1966) 1.77
The in vitro induction and release of a cell toxin by immune C57B1-6 mouse peritoneal macrophages. Cell Immunol (1972) 1.73
Four-hour urease test for distinguishing between Klebsiella and Enterobacter. Appl Microbiol (1969) 1.68
Lymphocyte in vitro cytotoxicity: mechanism of lymphotoxin-induced target cell destruction. J Immunol (1969) 1.60
Mesquite pollen--an aeroallergen in asthma and allergic rhinitis. J Allergy Clin Immunol (1977) 1.55
Lymphocyte in vitro cytotoxicity: correlation of derepression with release of lymphotoxin from human lymphocytes. J Immunol (1969) 1.53
Eradication of multi-drug resistant Acinetobacter from an intensive care unit. Surg Infect (Larchmt) (2001) 1.45
Production of lymphotoxin and migration inhibitory factor by established human lymphocytic cell lines. J Immunol (1970) 1.43
The human LT system. I. Physical-chemical heterogeneity of LT molecules released by mitogen activated human lymphocytes in vitro. Cell Immunol (1978) 1.40
Lymphocyte in vitro cytotoxicity: lymphotoxins of several mammalian species. Nature (1968) 1.39
A device for overcoming discoordination with metered-dose inhalers. J Allergy Clin Immunol (1993) 1.39
Guidelines for the clinical evaluation of hypersensitivity pneumonitis. Report of the Subcommittee on Hypersensitivity Pneumonitis. J Allergy Clin Immunol (1989) 1.35
Purification and characterization of an inhibitor (soluble tumor necrosis factor receptor) for tumor necrosis factor and lymphotoxin obtained from the serum ultrafiltrates of human cancer patients. Proc Natl Acad Sci U S A (1990) 1.34
The problem of sulfadiazine-resistant meningococci. Antimicrob Agents Chemother (Bethesda) (1966) 1.27
Inter- and intralaboratory variability in antibiotic susceptibility tests with Pseudomonas aeruginosa and Enterobacteriaceae. J Infect Dis (1976) 1.27
Unique temperature-sensitive nutritional requirements of bacteremic Escherichia coli isolates. J Clin Microbiol (1981) 1.26
Bacterial meningitis in the elderly. Arch Intern Med (1984) 1.26
Asthma and IgE antibodies induced by chromium and nickel salts. J Allergy Clin Immunol (1983) 1.24
Relationship of cloning inhibition factor, "lymphotoxin" factor, and proliferation inhibition factor release in vitro by mitogen-activated human lymphoctes. J Immunol (1975) 1.24
Role of Alternaria and Penicillium spores in the pathogenesis of asthma. J Allergy Clin Immunol (1985) 1.22
Correlates of sulfadiazine resistance in meningococci isolated from civilians. Antimicrob Agents Chemother (Bethesda) (1965) 1.22
Papain-induced asthma--physiological and immunological features. J Allergy Clin Immunol (1979) 1.17
Isolation and initial characterization of tumoricidal monokine(s) from the human monocytic leukemia cell line THP-1. J Natl Cancer Inst (1985) 1.16
Similarities and differences among specific tRNA's in mammalian tissues. Proc Natl Acad Sci U S A (1967) 1.15
An improved in vitro assay for lymphotoxin. Cell Immunol (1972) 1.14
Hypoxia induces a human macrophage cell line to release tumor necrosis factor-alpha and its soluble receptors in vitro. J Surg Res (1993) 1.14
Effect of antimicrobial agents on human polymorphonuclear leukocyte microbicidal function. Antimicrob Agents Chemother (1981) 1.12
Lymphocyte in vitro cytotoxicity: characterization of mouse lymphotoxin. Cell Immunol (1970) 1.12
Rapid identification of Escherichia, Klebsiella, and Enterobacter by use of a new urease test. Antimicrob Agents Chemother (Bethesda) (1968) 1.12
Phorbol myristate acetate induction of lymphotoxins from continuous human B lymphoid cell lines in vitro. J Biol Response Mod (1984) 1.10
Studies on in vitro models of cellular immunity: the role of T and B cells in the secretion of lymphotoxin. Cell Immunol (1973) 1.09
A simplified screening test for the diagnosis of allergy. West J Med (1990) 1.09
Experience with ampicillin in bacterial meningitis. Antimicrob Agents Chemother (Bethesda) (1965) 1.09
Large airway constriction in allergic rhinitis. J Allergy Clin Immunol (1977) 1.08
Cell-mediated immunity in vitro: a highly sensitive assay for human lymphotoxin. J Immunol (1974) 1.07
The human LT system. XII. Purification and functional studies of LT and "TNF-like" LT forms from a continuous human T cell line. J Immunol (1986) 1.05
The regulation of TNF receptor mRNA synthesis, membrane expression, and release by PMA- and LPS-stimulated human monocytic THP-1 cells in vitro. Cell Immunol (1991) 1.05
The human LT system. XI. Identification of LT and "TNF-like" forms from stimulated natural killers, specific and nonspecific cytotoxic human T cells in vitro. J Immunol (1986) 1.01
Tumour necrosis factor (TNF) binding proteins (soluble TNF receptor forms) with possible roles in inflammation and malignancy. Eur Cytokine Netw (1993) 1.00
Binding of human lymphotoxin to target-cell membranes and its relation to cell-mediated cytodestruction. Proc Natl Acad Sci U S A (1973) 0.98
Purified native and recombinant human alpha lymphotoxin [tumor necrosis factor (TNF)-beta] induces inflammatory reactions in normal skin. J Clin Immunol (1987) 0.98
Rat mitogen-stimulated lymphokine-activated T killer cells: production and effects on C6 glioma cells in vitro and in vivo in the brain of Wistar rats. J Immunother (1991) (1991) 0.97
Transcendental meditation and asthma. Respiration (1975) 0.96
Development and characterization of a clinically useful animal model of epithelial ovarian cancer in the Fischer 344 rat. Am J Obstet Gynecol (1996) 0.95
Postprandial exercise-induced anaphylaxis. J Allergy Clin Immunol (1983) 0.94
Regulation of growth of human diploid fibroblasts by factors elaborated by activated lymphoid cells. J Cell Physiol (1982) 0.93
Ampicillin levels in the cerebrospinal fluid during treatment of bacterial meningitis. Antimicrob Agents Chemother (Bethesda) (1965) 0.92
Mechanisms of lymphocyte-induced cell and tissue destruction in vitro. Am J Pathol (1970) 0.92
Lymphocyte effector molecules and cell-mediated immune reactions. Contemp Top Mol Immunol (1975) 0.91
Recombinant human alpha lymphotoxin (tumor necrosis factor-beta) induces peripheral neutrophilia and lymphopenia in the rat. Am J Pathol (1987) 0.91
Improved laboratory efficiency and diagnostic accuracy with new double-lumen-protected swab for for endometrial specimens. J Clin Microbiol (1979) 0.91
Allergic bronchopulmonary aspergillosis caused by Aspergillus ochraceus. Am J Clin Pathol (1978) 0.90
Analysis and comparison of the luminol-dependent chemiluminescence responses of alveolar macrophages and neutrophils. J Reticuloendothel Soc (1980) 0.90
Relation of virulence of Escherichia coli in septicemia and urinary tract infection to temperature-sensitive growth in minimal medium. J Infect Dis (1980) 0.89
Trauma causes sustained elevation of soluble tumor necrosis factor receptors. J Am Coll Surg (1994) 0.89
Spontaneous release of interleukin-6 by primary cultures of lymphoid and tumor cell populations purified from human ovarian carcinoma. J Interferon Cytokine Res (1995) 0.88
Lymphokines--the mediators of cellular immunity. Ser Haematol (1972) 0.88
The presence of antibodies to lymphotoxin and tumor necrosis factor in normal serum. Arthritis Rheum (1989) 0.88
Improved 18-hour methyl red test. Appl Microbiol (1970) 0.88
Lymphocyte in vitro cytotoxicity: mechanism of human lymphotoxin-induced target cell destruction. Cell Immunol (1973) 0.87
The role of lymphotoxin in target cell destruction by mitogen-activated human lymphocytes. I. The correlation of target cell sensitivity to lymphotoxin and the intact lymphocyte. Cell Immunol (1975) 0.87
Asthma, arsenic, and cancer. J Allergy (1969) 0.87
Role of 55- and 75-kDa tumor necrosis factor membrane receptors in the regulation of intercellular adhesion molecules-1 expression by HL-60 human promyelocytic leukemia cells in vitro. J Immunol (1993) 0.87
Mechanisms of lymphocyte-mediated cytotoxicity. I. The effects of anti-human lymphotoxin antisera on the cytolysis of allogeneic B cell lines by MLC-sensitized human lymphocytes in vitro. J Immunol (1981) 0.87
Tobramycin: maternal-fetal pharmacology. Antimicrob Agents Chemother (1977) 0.86
Evaluation of urine culture screening by light-scatter photometry. Am J Clin Pathol (1981) 0.86
In-use contamination of intravenous solutions in flexible plastic containers. Am J Hosp Pharm (1972) 0.86
In vitro lymphocyte cytotoxicity. I. Evidence of multiple cytotoxic molecules secreted by mitogen activated human lymphoid cells in vitro. Cell Immunol (1976) 0.86
Incidence of serum antibodies to several Aspergillus species and to Candida albicans in cystic fibrosis. Am Rev Respir Dis (1976) 0.86
Mechanism of release of soluble forms of tumor necrosis factor/lymphotoxin receptors by phorbol myristate acetate-stimulated human THP-1 cells in vitro. J Immunol (1993) 0.86
Toxigenic Escherichia coli and childhood diarrhea. West J Med (1976) 0.85
Production of lymphotoxin by isolated human tonsillar B lymphocytes and B lymphocyte cell lines. J Clin Invest (1989) 0.85
Lymphotoxins: a multicomponent system of cell-lytic lymphocyte-released effector molecules. Lymphokine Res (1982) 0.85
Identification of TNF-LT blocking factor(s) in the serum and ultrafiltrates of human cancer patients. Lymphokine Res (1990) 0.85
Septicemia in acute leukemia. Med Pediatr Oncol (1978) 0.85
Prostaglandin-E2 regulation of tumor necrosis factor receptor release in human monocytic THP-1 cells. Cell Immunol (1996) 0.84
Nosocomial infection and antibiotic utilization in geriatric patients: a pilot prospective surveillance program in skilled nursing facilities. Gerontology (1992) 0.84
Effects of cytokines combined with high-dose gamma irradiation on the expression of major histocompatibility complex molecules and intercellular adhesion molecule-1 in human ovarian cancers. Int J Cancer (1996) 0.84
Trauma causes early release of soluble receptors for tumor necrosis factor. J Trauma (1993) 0.83
Relationship of CIF, LT, and PIF released in vitro by activated human lymphocytes. II. A further functional comparison of LT and PIF activities on HeLa and L-929 target cells. J Immunol (1976) 0.83
Lymphotoxin detected in the blister fluid of bullous pemphigoid patients. J Clin Immunol (1984) 0.83
Anaphylactoid reactions to tolmetin after interrupted dosage. West J Med (1985) 0.82
Human lymphotoxin: purification and some properties. Proc Natl Acad Sci U S A (1973) 0.82